SEBI Reg. Investment Advisor

Download App

Help Center Subscribe

Recent:

Top Pharma Companies in India by Market Cap

BSE Sensex 76391.39
363.66 (-0.47%)

Filter

Top Pharma Companies in India as on Jul-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
121	Kopran Ltd.	Q V PT	975 Small Cap	200.50 (-0.67%)	32.06	2.18	8.61	14.34	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
122	Shree Ganesh Remedies Ltd.	Q V PT	845 Small Cap	660.10 (0.32%)	47.53	5.18	13.20	20.49	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
123	Anuh Pharma Ltd.	Q V+ PT	810 Small Cap	79.16 (-2.02%)	19.73	2.3	16.60	20.73	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
124	Fabtech Technologies Ltd.	Q V PT	654 Small Cap	148.85 (1.22%)	26.95	1.68	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
125	Nectar Lifesciences Ltd.	Q V PT	204 Small Cap	10.48 (-0.10%)	N/A	0.35	-6.71	-232.05	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Rubicon Research	1,531.10	4.52%
Bliss GVS Pharma	462.85	3.28%
Tarsons Products	315.85	2.70%
Marksans Pharma	246.50	2.32%
Piramal Pharma	180.85	2.15%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Acutaas Chemicals	3,455.90	-5.77%
Fermenta Biotech	401.95	-4.49%
Orchid Pharma	963	-3.84%
Cohance Lifesciences	422.40	-3.77%
Dishman Carbogen Amc	179.45	-3.70%

News about Top Pharma Companies in India

Jul, 2026

Kopran informs about record date

Kopran has informed that the record date for payment of Dividend is Tuesday, August 11, 2026 subject to tax deducted at source, if declared by the Members at the Annual General Meeting of the Company to be held on Tuesday, August 18, 2026.

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

Kopran informs about certificate

Kopran has certified that the Company has complied with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the Quarter ended June 30, 2026. The Certificate is issued based on the information and Certificate received from Bigshare Services.

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

Fabtech Technologies informs about outcome of postal ballot

Fabtech Technologies has informed that the Company had sought consent from members of the Company on the following resolutions through Postal Ballot notice dated May 25, 2026: Appointment of Rupal Dhiren Haria (DIN: 10624643) as a Non-Executive Independent Director of the Company; and Appointment of Bharti Khanna (DIN: 05147844) as a Non-Executive Independent Director of the Company. Based on the report issued by our Scrutinizer, CS Rachana Shanbhag, Partner of DA Kamat & Co., Company Secretaries, (FCS: 8227/ CP: 9297), the above resolutions have been passed and the same are deemed to have been approved on the last date of e-voting period i.e., Tuesday, June 30, 2026. The voting results in the format prescribed under Regulation 44(3) of SEBI. Listing. Regulations, along with the Scrutinizer's Report on remote e-voting, in respect of above resolutions are attached. The Voting Results along with the Scrutinizer's Report are available on the Company's website www.fabtechnologies.com and also on the website of NSDL at https://www.evoting.nsdl.com/.

The above information is a part of company's filings submitted to BSE.

Jun, 2026

Fabtech Technologies secures contract worth Rs 31.23 crore

The contract is for the critical internal infrastructure scope of a new Veterinary Vaccine Manufacturing Facility in Botswana

Jun, 2026

Fabtech Technologies informs about new order

Fabtech Technologies has informed that the Company has secured an order/contract from Botswana Vaccine Institute. The details required under Regulation 30 of the SEBI Listing Regulations read with SEBI Circular No. SEBI/ HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 are attached as ‘Annexure A’.

The above information is a part of company’s filings submitted to BSE.

May, 2026

Fabtech Technologies informs about newspaper publication

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Fabtech Technologies has informed that they have published Postal Ballot Notice containing the details of remote e-voting and other related information in the following newspapers dated May 30, 2026: 1. Financial Express (English) 2. Loksatta (Marathi- Regional Language). The copy of the above newspaper publication is enclosed and the same is also disseminated on the website of the Company.

The above information is a part of company’s filings submitted to BSE.

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Sun Pharmaceutical Industries Ltd.	4,66,179 Crore
2	Divis Laboratories Ltd.	1,96,095 Crore
3	Torrent Pharmaceuticals Ltd.	1,91,530 Crore
4	Apollo Hospitals Enterprise Ltd.	1,28,516 Crore
5	Cipla Ltd.	1,14,318 Crore
6	Zydus Lifesciences Ltd.	1,12,693 Crore
7	Lupin Ltd.	1,10,002 Crore
8	Mankind Pharma Ltd.	1,05,068 Crore
9	Max Healthcare Institute Ltd.	1,05,274 Crore
10	Dr. Reddys Laboratories Ltd.	98,742 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	28,735	61,408	39.57	12.93	27.13	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	5,066	1,91,530	88.53	22.78	45.95	29.04
Lupin Ltd. (M)	Somewhat Good	2,396	1,10,002	20.63	4.91	11.93	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,441	43,218	40.93	9.55	27.65	25.35
Alkem Laboratories Ltd. (M)	Very Good	5,607	66,822	30.58	4.77	22.18	17.86

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	1,568	85,232	90.72
Sai Life Sciences Ltd. (S)	Very Good	1,240	26,541	51.95
Torrent Pharmaceuticals Ltd. (L)	Very Good	5,066	1,91,530	42.54
Aurobindo Pharma Ltd. (M)	Very Good	1,524	88,203	36.43
Ajanta Pharma Ltd. (M)	Very Good	3,441	43,218	26.65
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Very Good	1,240	26,541	77.72	10.58	40.87	17.75
Ajanta Pharma Ltd. (M)	Very Good	3,441	43,218	40.93	9.55	27.65	13.54
Mankind Pharma Ltd. (M)	Very Good	2,557	1,05,068	51.57	6.43	32.30	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,114	1,12,693	22.36	4.33	13.70	13.52
Lupin Ltd. (M)	Somewhat Good	2,396	1,10,002	20.63	4.91	11.93	13.02

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Lupin Ltd. (M)	Somewhat Good	2,396	1,10,002	20.63	4.91	11.93	32.37
Abbott India Ltd. (M)	Very Good	28,735	61,408	39.57	12.93	27.13	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,167	98,742	30.64	2.62	15.71	15.75
Zydus Lifesciences Ltd. (M)	Very Good	1,114	1,12,693	22.36	4.33	13.70	14.72
Sun Pharmaceutical Industries Ltd. (L)	Very Good	1,954	4,66,179	40.61	5.58	23.28	14.41

You have 9 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now

Create stable, long-term investment portfolio with strong, consistent stocks.

Start Research-backed Investing ...Now. Subscribe to Sapphire

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Kopran informs about record date

Kopran informs about certificate

Fabtech Technologies informs about outcome of postal ballot

Fabtech Technologies secures contract worth Rs 31.23 crore

Fabtech Technologies informs about new order

Fabtech Technologies informs about newspaper publication

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.